#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Interstitial lung disease Keratosis follicular Anal cancer Squamous cell carcinoma of the cervix High-grade B-cell lymphoma Chronic myelomonocytic leukaemia Multiple system atrophy Pulmonary alveolar haemorrhage Carcinoid tumour Kawasaki's disease Metastatic malignant melanoma Rhabdomyosarcoma recurrent Loss of consciousness Testicular leiomyosarcoma Inclusion body myositis More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Sarcoidosis – Treatment Rhabdomyosarcoma – Basic Information Focal segmental glomerulosclerosis – Diagnostics Synovial sarcoma Netherton’s syndrome – Treatment Hereditary angioedema – Life with Disease SAPHO syndrome Pulmonary fibrosis – Treatment Rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iph5201 Lovo-B Cefiderocol Glycerol Pregabalin Dronabinol GSKVX000000034794 Dexamethasone LTI-03 Glofitamab Alendronate Sodium Monohydrate Ttf-Ngr Amniotic Membrane, Human Sparsentan Elafibranor Indapamide Gimeracil Tadalafil Zinc Acexamate AUROCELL-TX More therapies…

    Learn about Your Condition

    Epithelioid sarcoma Congenital ureteric anomaly Primary hyperoxaluria Myelodysplastic syndrome Malignant melanoma stage II Macular degeneration Leukoencephalopathy Colon cancer stage IV Post-traumatic stress disorder Cervix carcinoma stage III Pneumonia bacterial Thalassaemia Joint stabilisation Rhabdomyosarcoma recurrent Sarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Perineal injury

  • Comparing Lidocaine-Prilocaine Cream and Lidocaine Injection for First-Degree Perineal Tear Repair in Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Perineal injury
    Investigated Drugs:
    • Lidocaine
    • Prilocaine
    • Lidocaine Hydrochloride
    Spain
  • Study on Patient-Controlled Sedation with Propofol for Women Undergoing Repair of Obstetric Perineal Tears Using Ropivacaine, Lidocaine, and Mepivacaine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Perineal injury
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Anhydrous Ropivacaine Hydrochloride
    • Mepivacaine Hydrochloride
    Sweden
  • Study on Amoxicillin and Clavulanic Acid to Prevent Infection in Women with Obstetric Perineal Tear

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Perineal injury
    Investigated Drugs:
    • Amoxicillin
    • Clavulanic Acid
    Denmark

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!